Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 9(1): 7841, 2019 05 21.
Article in English | MEDLINE | ID: mdl-31110183

ABSTRACT

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

2.
Sci Rep ; 9(1): 3074, 2019 02 28.
Article in English | MEDLINE | ID: mdl-30816122

ABSTRACT

Gram-negative bacteria are refractory to the action of many antibiotics due to their impermeable outer membrane. An important player of the immune system is the complement system, a protein network in serum that directly kills Gram-negative bacteria through pore-formation by the Membrane Attack Complexes (MAC). We here show that the MAC rapidly perforates the outer membrane but that inner membrane damage, which is essential for killing, is relatively slow. Importantly, we demonstrate that MAC-induced outer membrane damage sensitizes Gram-negative bacteria to otherwise ineffective, Gram-positive-specific, antimicrobials. Synergy between serum and nisin was observed for 22 out of 53 tested Gram-negative clinical isolates and for multi-drug resistant (MDR) blood isolates. The in vivo relevance of this process is further highlighted by the fact that blood sensitizes a MDR K. pneumoniae strain to vancomycin. Altogether, these data imply that antibiotics that are considered ineffective to treat infections with Gram-negatives may have different functional outcomes in patients, due to the presence of the complement system.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Outer Membrane/drug effects , Complement System Proteins/immunology , Gram-Negative Bacteria/drug effects , Nisin/pharmacology , Vancomycin/pharmacology , Bacterial Outer Membrane/immunology , Complement Membrane Attack Complex/immunology , Drug Resistance, Multiple, Bacterial , Gram-Negative Bacteria/immunology , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/immunology , Gram-Positive Bacteria/drug effects , Humans
3.
mBio ; 6(3): e00335, 2015 Jun 04.
Article in English | MEDLINE | ID: mdl-26045537

ABSTRACT

UNLABELLED: Although Staphylococcus aureus is best known for infecting humans, bovine-specific strains are a major cause of mastitis in dairy cattle. The bicomponent leukocidin LukMF', exclusively harbored by S. aureus of ruminant origin, is a virulence factor associated with bovine infections. In this study, the molecular basis of the host specificity of LukMF' is elucidated by identification of chemokine receptor CCR1 as its target. Bovine neutrophils, the major effector cells in the defense against staphylococci, express significant cell surface levels of CCR1, whereas human neutrophils do not. This causes the particular susceptibility of bovine neutrophils to pore formation induced by LukMF'. Bovine S. aureus strains produce high levels of LukMF' in vitro. In culture supernatant of the mastitis field isolate S1444, LukMF' was the most important cytotoxic agent for bovine neutrophils. In a fibrin gel matrix, the effects of the in situ secreted toxins on neutrophils migrating toward S. aureus were visualized. Under these physiological ex vivo conditions, bovine S. aureus S1444 efficiently killed approaching neutrophils at a distance through secretion of LukMF'. Altogether, our findings illustrate the coevolution of pathogen and host, provide new targets for therapeutic and vaccine approaches to treat staphylococcal diseases in the cow, and emphasize the importance of staphylococcal toxins in general. IMPORTANCE: This study explains the mechanism of action of LukMF', a bicomponent toxin found in bovine lineages of S. aureus that is associated with mastitis in cattle. At a molecular level, we describe how LukMF' can specifically kill bovine neutrophils. Here, we demonstrate the contribution of toxins in the determination of host specificity and contribute to the understanding of mechanisms of coevolution of pathogen and host. Our study provides new targets that can be used in therapeutic and vaccine approaches to treat staphylococcal diseases in the cow. We also demonstrate the importance of toxins in specific elimination of immune cells, which has broader implications, especially in human infections.


Subject(s)
Bacterial Proteins/metabolism , Leukocidins/metabolism , Mastitis, Bovine/microbiology , Neutrophils/drug effects , Neutrophils/physiology , Receptors, CCR1/metabolism , Staphylococcus aureus/pathogenicity , Animals , Cattle , Cell Survival/drug effects , Staphylococcus aureus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...